Precision of impedance cardiography measurements of cardiac output in pacemaker patients

Advances in atrioventricular and interventricular optimization of cardiac resynchronization therapy - what's the gold standard?

INTRODUCTION

Cardiac resynchronization therapy (CRT) is one of the most important advances in heart failure management in the last twenty years. Approximately one-third of patients appear not to respond to therapy. Although there are a number of possible mechanisms for non-response, an important factor is suboptimal atrioventricular (AV) and interventricular (VV) timing intervals. There remains controversy over whether routinely optimizing intervals is necessary and there is no agreed gold standard methodology. Optimization has classically been performed using echocardiography which has limits related to resource use, time-cost and variable reproducibility. Newer optimization methods using device-based sensors and algorithms show promise in reducing heart-failure hospitalization compared with echocardiography. Areas covered: This review outlines the rationale for optimization, the principles of AV and VV optimization, the standard echocardiographic approach and newer device-based algorithms and the evidence base for their use. Expert commentary: The incremental gains of optimization are likely to be real, but small, compared to the overall improvement gained from cardiac resynchronization itself. At this time routine optimization may not be mandatory but should be performed where there is no response to CRT. Device-based optimization algorithms appear to be practical and in some cases, deliver superior clinical outcomes compared to echocardiography.

Effects of AV-delay optimization on hemodynamic parameters in patients with VDD pacemakers

AIM

Atrioventricular (AV) delay optimization improves hemodynamics and clinical parameters in patients treated with cardiac resynchronization therapy and dual-chamber-pacemakers (PM). However, data on optimizing AV delay in patients treated with VDD-PMs are scarce. We, therefore, investigated the acute and chronic effects of AV delay optimization on hemodynamics in patients treated with VDD-PMs due to AV-conduction disturbances.

METHODS

In this prospective, single-center interventional trial, we included 64 patients (38 men, 26 women, median age: 77 (70-82) years) with implanted VDD-PM. AV-delay optimization was performed using a formula based on the surface electrocardiogram (ECG). Hemodynamic parameters (stroke volume (SV), cardiac output (CO), heart rate (HR), and blood pressure (BP)) were measured at baseline and follow-up after 3 months using impedance cardiography.

RESULTS

Using an ECG formula for AV-delay optimization, the AV interval was decreased from 180 (180-180) to 75 (75-100) ms. At baseline, AV-delay optimization led to a significant increase of both SV (71.3 ± 15.8 vs. 55.3 ± 12.7 ml, p < 0.001, for optimized AV delay vs. nominal AV interval, respectively) and CO (5.1 ± 1.4 vs. 3.9 ± 1.0 l/min, p < 0.001), while HR and BP remained unchanged. At follow-up, the improvement in CO remained stable (4.9 ± 1.3 l/min, p = 0.09), while SV slightly, but significantly, decreased (to 65.1 ± 17.6, p < 0.01).

CONCLUSION

AV-delay optimization in patients treated with VDD-PMs exhibits immediate beneficial effects on hemodynamic parameters that are sustained for 3 months.

Comparison of the acute hemodynamic effect of right ventricular apex, outflow tract, and dual-site right ventricular pacing

BACKGROUND

We studied the acute effect of pacing at the right ventricular outflow tract (RVOT), right ventricular apex (RVA) and simultaneous RVA and RVOT-dual-site right ventricular pacing (DuRV) in random order on systolic function using impedance cardiography.

METHODS

Seventy-three patients (46 males), aged 52-89 years (mean 71.4 years) subjected to routine dual chamber pacemaker implantation with symptomatic chronic II or atrioventricular block, were included to the study.

RESULTS

DuRV pacing resulted in significantly higher cardiac index (CI) in comparison to RVOT and RVA and CI at RVOT was higher than at RVA pacing (2.46 vs 2.35 vs 2.28; P < 0.001). In patients with ejection fraction >50% significantly higher CI was observed during DuRV pacing when compared to RVOT and RVA pacing and there was no difference of CI between RVOT and RVA pacing (2.53 vs 2.41 vs 2.37; P < 0.001). In patients with ejection fraction <50%, DuRV and RVOT pacing resulted in significantly higher CI in comparison to RVA pacing while no difference in CI was observed between RVOT and DuRV pacing (2.28 vs 2.21 vs 2.09; P < 0.001).

CONCLUSION

Dual-site right ventricular pacing in comparison to RVA pacing improved cardiac systolic function. RVOT appeared to be more advantageous than RVA pacing in patients with impaired, but not in those with preserved left ventricular function. No clear hemodynamic benefit of DuRV in comparison to RVOT pacing in patients with impaired systolic function was observed.

Dual chamber versus single chamber ventricular pacemakers for sick sinus syndrome and atrioventricular block

BACKGROUND

Dual chamber pacing or single chamber atrial pacing ('physiologic' pacing) is believed to have an advantage over single chamber ventricular pacing in that it resembles cardiac physiology more closely by maintaining atrioventricular (AV) synchrony and dominance of the sinus node, which in turn may reduce cardiovascular morbidity and mortality thus contributing to patient survival and quality of life. However, a significant proportion of pacemakers currently implanted are single chamber ventricular pacemakers.

OBJECTIVES

The objective of this review was to assess the short- and long-term clinical effectiveness of dual chamber pacemakers compared to single chamber ventricular pacemakers in adults with AV block, sick sinus syndrome or both. An additional objective was to assess separately any potential differences in effectiveness between dual chamber pacing and single chamber atrial pacing. The clinical effectiveness of single chamber atrial pacing versus single chamber ventricular pacing was not examined.

SEARCH STRATEGY

The Cochrane Controlled Trials Register (The Cochrane Library Issue 3, 2002), MEDLINE (1966 to 2002), EMBASE (1980 to 2002) and the Science Citation Index (1980 to 2002) were searched on 19th August 2002. Citation lists and web sites were checked and researchers in the field contacted.

SELECTION CRITERIA

Parallel group or crossover randomised controlled trials of at least 48 hours duration comparing dual chamber pacing and single chamber ventricular pacing, and investigating cardiovascular morbidity, mortality, patient related quality of life, exercise capacity and complication rates.

DATA COLLECTION AND ANALYSIS

Data was extracted onto pre-piloted data extraction forms. Quality assessment was undertaken using a checklist, with a sub-sample of quality data independently extracted by a second reviewer. Where appropriate data was available, meta-analysis was performed. Where meta-analysis was not possible, the number of studies showing a positive, neutral or negative direction of effect and statistical significance were simply counted.

MAIN RESULTS

Five parallel and 26 crossover randomised controlled trials were identified. The quality of reporting was found to be poor. Pooled data from parallel studies shows a statistically non-significant preference for physiologic pacing (primarily dual chamber pacing) for the prevention of stroke, heart failure and mortality, and a statistically significant beneficial effect regarding the prevention of atrial fibrillation (odds ratio (OR) 0.79, 95% CI 0.68 to 0.93). Both parallel and crossover studies favour dual chamber pacing with regard to pacemaker syndrome (parallel: Peto OR 0.11, 95% CI 0.08 to 0.14; crossover: standardised mean difference (SMD) -0.74, 95% CI - 0.95 to -0.52). Pooled data from crossover studies shows a statistically significant trend towards dual chamber pacing being more favourable in terms of exercise capacity (SMD -0.24, 95% CI -0.03 to -0.45). No individual studies reported a significantly more favourable outcome with single chamber ventricular pacing.

REVIEWERS' CONCLUSIONS

This review shows a trend towards greater effectiveness with dual chamber pacing compared to single chamber ventricular pacing, which supports the current British Pacing and Electrophysiology Group's Guidelines regarding atrioventricular block. Additional randomised controlled trial evidence from ongoing trials in this area will further inform the debate.

Effects of sensor selection on exercise stroke volume in pacemaker dependent patients

The effects of sensor selection and sensor blending on the cardiovascular response to graded exercise was evaluated in 10 patients (age 74 +/- 2 yrs; 7 men and 3 women) implanted with a dual sensor rate adaptive VVIR pacemaker (Vitatron Topaz model 515). Patients underwent three graded exercise tests (GXT) with sensor programming randomly assigned. For a given graded exercise text the pacemaker was programmed into activity sensing (ACT), QT sensing, or dual sensing (ACT = QT). Data were recorded at rest and during each stage of the graded exercise text. Oxygen uptake (VO2) was measured continuously using a Q Plex I system. Heart rate (HR), stroke volume (SV), and cardiac output (Qc) were measured by impedance cardiography. Systolic time intervals were calculated from simultaneous recordings of the ECG, phonocardiogram, and the impedance cardiogram. In response to the GXT no differences in peak VO2 were observed across the three sensor settings. Regardless of the sensor setting Qc increased linearly with each increment in VO2. The HR response to ACT only pacing was significantly higher than in the other two pacing conditions. During ACT only pacing SV failed to rise in response to exercise. The increased exercise Qc during QT and ACT = QT pacing were mediated by significant increases in both HR and SV. The QT and dual pacing conditions were also associated with longer diastolic filling times. The data indicate that the mechanisms responsible for the increase Qc during exercise were different for ACT versus ACT = QT or QT sensor-driven pacing.

Evaluation of impedance cardiography: comparison of NCCOM3-R7 with Fick and thermodilution methods

OBJECTIVE

To assess the degree of error of the BoMed NCCOM3 model revision seven (R7) impedance cardiograph in determining stroke volume and estimated cardiac output.

DESIGN

Three-group, within-subject, repeated measures design.

SAMPLE

Group 1: patients (n = 17) with heart disease undergoing an elective coronary angiogram; group 2: patients (n = 28) after elective heart surgery; and group 3: healthy volunteers (n = 28).

MEASUREMENT

Cardiac output was determined by the BoMed NCCOM3-R7 impedance cardiograph, Fick principle, and thermodilution method. The NCCOM3-R7 was compared with the direct Fick and thermodilution methods in groups 1 and 2, respectively, to estimate validity coefficients. In group 3, repeated measures were obtained with the NCCOM3-R7 to calculate reliability coefficients.

RESULTS

The NCCOM3-R7 underestimated Fick measurements by 1.050 +/- 1.529 L/min at rest and 1.505 +/- 2.214 L/min during exercise. Correlation coefficients of 0.684 at rest (p = 0.001) and 0.219 during exercise (p = 0.248) were obtained. The NCCOM3-R7 underestimated thermodilution values by 0.425 +/- 1.325 L/min in subjects initially after heart surgery and 0.358 +/- 1.235 L/min 2 to 4 hours later. Correlation coefficients of 0.547 (p = 0.002) and 0.505 (p = 0.004) were obtained for the two time periods, respectively. A reliability coefficient of 0.837 was calculated with healthy subjects.

CONCLUSION

The NCCOM3-R7 has a clinically unacceptable level of error for evaluating cardiac performance in patients with heart disease.

A review of impedance cardiography

OBJECTIVE

To review the reliability and validity estimates of impedance cardiography to assess its empirical precision and clinical usefulness.

DATA SOURCE

Empirical and theoretical literature mainly within the last 10 years.

DATA SYNTHESIS

Descriptive statistics used to summarize the accuracy and use of impedance cardiography to estimate stroke volume.

CONCLUSIONS

Estimation of cardiac output is presently a core component of optimizing cardiac function in many patient populations. Impedance cardiography, which initially used a formula developed by Kubicek et al. and recently a formula developed by Sramek and Bernstein, remains controversial with regard to its accuracy and use in research and clinical practice.

Impedance cardiography for cardiac output estimation in pacemaker patients: review of the literature

Impedance cardiography permits noninvasive beat-to-beat determination of cardiac output, the product of the amplitude of the first derivative of thoracic impedance signal (dZ/dt), the ventricular ejection time, and heart rate corrected by the distance between the measuring electrodes. Its use is based on: (1) the dZ/dt signal that originates from the upper thorax; (2) the ventricular ejection period measured by the dZ/dt curve that occurs between the opening and closing of the aortic valve; (3) the dZ/dt curve is similar in morphology and timing to the aortic flow curve measured by an electromagnetic flowmeter with a significant linear correlation (r = 0.9) between dZ/dt and peak aortic flow; (4) similarity of the linear correlation between stroke volume, determined by the flowmeter and the impedance signal; and (5) significant reduction of the dZ/dt signal by 90% follows simultaneous occlusion of the aorta and the pulmonary artery. The rapid systolic portion of the impedance signal occurs only when blood is ejected into the aorta and is independent of right ventricular ejection. Most studies comparing impedance cardiography results with standard cardiac output determination have shown a correlation of 0.7-0.9. While the accuracy of impedance cardiography remains controversial and can be affected by the inherent limitations of the technique and by low cardiac output, intracardiac shunts, and valvular regurgitation, the high reproducibility of the method is established and may be comparable or superior to other commonly used techniques. When accurate determination of cardiac output is crucial, impedance cardiography may be used in conjunction with a standard technique to establish a baseline reference, thereby permitting further analysis. If only the trend need be followed, the high reproducibility of impedance cardiography measurements allows small changes in cardiac output to be detected on a frequent and ongoing basis. The ease and precision of this technique warrants its more widespread use in the assessment of pacemaker patients. Further use of this promising technique will allow a better definition of its role in the assessment of a wide range of cardiac patients.